Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii–calcoaceticus complex
暂无分享,去创建一个
C. Murray | K. Akers | K. Mende | M. Beckius | A. Markelz | Tatjana P. Calvano | Alice E. Barsoumian | Ryan Cassidy
[1] D. Hospenthal,et al. Carbapenem Susceptibility Testing Errors Using Three Automated Systems, Disk Diffusion, Etest, and Broth Microdilution and Carbapenem Resistance Genes in Isolates of Acinetobacter baumannii-calcoaceticus Complex , 2011, Antimicrobial Agents and Chemotherapy.
[2] R. Venezia,et al. Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients , 2011, European Journal of Clinical Microbiology & Infectious Diseases.
[3] A. Sundsfjord,et al. Emergence of OXA-carbapenemase- and 16S rRNA methylase-producing international clones of Acinetobacter baumannii in Norway. , 2011, Journal of medical microbiology.
[4] Yee-Chun Chen,et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] A. Renault,et al. Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak. , 2011, The Journal of hospital infection.
[6] M. Ilkit,et al. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. , 2011, Medical mycology.
[7] S. Valdezate,et al. Clonal Diversity of Nosocomial Epidemic Acinetobacter baumannii Strains Isolated in Spain , 2010, Journal of Clinical Microbiology.
[8] P. Courvalin,et al. Efflux-Mediated Antibiotic Resistance in Acinetobacter spp , 2010, Antimicrobial Agents and Chemotherapy.
[9] N. Gordon,et al. Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii , 2010, Journal of Clinical Pathology.
[10] R. Saito,et al. Evaluation of a chromogenic agar medium for the detection of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae , 2010, Letters in applied microbiology.
[11] D. Hospenthal,et al. Prevalence of multidrug-resistant organisms recovered at a military burn center. , 2010, Burns : journal of the International Society for Burn Injuries.
[12] K. Carroll,et al. Evaluation of BBL CHROMagar VanRE for Detection of Vancomycin-Resistant Enterococci in Rectal Swab Specimens , 2010, Journal of Clinical Microbiology.
[13] F. Baquero,et al. Assessment of prevalence and changing epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae fecal carriers using a chromogenic medium. , 2010, Diagnostic microbiology and infectious disease.
[14] M. Falagas,et al. Treatment of Acinetobacter infections , 2010 .
[15] Hee-Young Yang,et al. Evaluation of commercial selective agars in screening for methicillin-resistant Staphylococcus aureus. , 2010, Annals of clinical and laboratory science.
[16] C. Murray,et al. CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex. , 2010, Diagnostic microbiology and infectious disease.
[17] J. Boyce,et al. Evaluation of a New Selective Medium, BD BBL CHROMagar MRSA II, for Detection of Methicillin-Resistant Staphylococcus aureus in Stool Specimens , 2010, Journal of Clinical Microbiology.
[18] K. Chapin,et al. Evaluation of a New Selective Medium, BD BBL CHROMagar MRSA II, for Detection of Methicillin-Resistant Staphylococcus aureus in Different Specimens , 2010, Journal of Clinical Microbiology.
[19] P. Nordmann,et al. Use of ChromID Extended-Spectrum β-Lactamase Medium for Detecting Carbapenemase-Producing Enterobacteriaceae , 2010, Journal of Clinical Microbiology.
[20] C. Murray,et al. Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex , 2010, Journal of Clinical Microbiology.
[21] N. Gordon,et al. Evaluation of CHROMagar Acinetobacter for Detection of Enteric Carriage of Multidrug-Resistant Acinetobacter baumannii in Samples from Critically Ill Patients , 2009, Journal of Clinical Microbiology.
[22] Z. Samra,et al. Evaluation of CHROMagar KPC for Rapid Detection of Carbapenem-Resistant Enterobacteriaceae , 2008, Journal of Clinical Microbiology.
[23] Lisa L Maragakis,et al. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Clinical,et al. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement , 2008 .
[25] J. Patel,et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] M. C. Albrecht,et al. Impact of Acinetobacter infection on the mortality of burn patients. , 2006, Journal of the American College of Surgeons.
[27] S. Davies,et al. Evaluation of a new selective medium for methicillin-resistant Staphyloccocus aureus. , 2001, Journal of medical microbiology.
[28] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .